Kolexia
Lanteri Minet Michel Neurologie
Lanteri Minet Michel
Neurologie
Hôpital Cimiez
Nice, France
241 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Migraines Céphalée Névralgie Céphalées Algie vasculaire de la face Douleur chronique Abus de médicaments sur ordonnance Céphalées primitives Céphalées secondaires

Collaborateurs

Voir plus
Lucas Christian
Lucas Christian
Hôpital Roger Salengro, Lille, France
Donnet Anne
Donnet Anne
Hôpital La Timone, Marseille, France
Fontaine Denys
Fontaine Denys
Hôpital Pasteur, Nice, France
Valade Dominique
Valade Dominique
Cabinet libéral, Paris, France

Industries

Voir plus
Lundbeck
52 collaboration(s)
Dernière en 2023
Lilly
40 collaboration(s)
Dernière en 2022
Abbvie
26 collaboration(s)
Dernière en 2023
Teva
26 collaboration(s)
Dernière en 2022

Dernières activités

Voir plus
Patient Sex in Prescribing CGRP Receptor Antagonists for Migraine.
JAMA neurology   26 février 2024
Safety and efficacy of atogepant for the preventive treatment of episodic migraine in adults for whom conventional oral preventive treatments have failed (ELEVATE): a randomised, placebo-controlled, phase 3b trial.
The Lancet. Neurology   13 février 2024
NGO: French Database of Occipital Nerves Stimulation in the Treatment of Refractory Chronic Headache Disorders
Essai Clinique (CHU Nice)   08 février 2024
Generalizability of clinical trial efficacy results to a real-world population: An example in migraine prevention.
Journal of managed care & specialty pharmacy   15 décembre 2023
PREDIBACK 2: Identification of Outcome Predictors and Stratification of Responder Profiles Implanted With Spinal Cord Stimulation. An AI-based-pathway & Algorithmic Approach to Treat Failed Back Surgery Syndrome Patients
Essai Clinique (CHU Poitiers)   05 décembre 2023
Design of the contemporary prospective understanding of migraine real-world evidence (CAPTURE) study
Abstracts from the World Congress of Neurology (WCN 2023)   01 décembre 2023
Pre- and post-headache phases of migraine: multi-country results from the CaMEO - International Study.
The journal of headache and pain   08 novembre 2023
One-year prospective real-world assessment of effectiveness and safety of erenumab in migraine prevention: results of the French FHU INOVPAIN registry study.
The journal of headache and pain   08 novembre 2023
ELEVATE: A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-controlled, Parallel-Group Study to Evaluate the Efficacy, Safety, and Tolerability of Oral Atogepant for the Prophylaxis of Migraine in Participants With Episodic Migraine Who Have Previously Failed 2 to 4 Classes of Oral Prophylactic Treatments (ELEVATE)
Essai Clinique (Allergan)   19 septembre 2023
DELIVER: Interventional, Randomized, Double-blind, Parallel-group, Placebo-controlled Study With an Extension Period to Evaluate the Efficacy and Safety of Eptinezumab for the Prevention of Migraine in Patients With Unsuccessful Prior Preventive Treatments
Essai Clinique (Lundbeck)   08 septembre 2023